Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

USA - NYSE:CMBT - BE0003816338 - Common Stock

9.63 USD
0 (0%)
Last: 10/17/2025, 8:04:00 PM
9.5079 USD
-0.12 (-1.27%)
After Hours: 10/17/2025, 8:04:00 PM
Fundamental Rating

4

CMBT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT scores excellent on profitability, but there are concerns on its financial health. While showing a medium growth rate, CMBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CMBT was profitable.
CMBT had a positive operating cash flow in the past year.
Of the past 5 years CMBT 4 years were profitable.
CMBT had a positive operating cash flow in 4 of the past 5 years.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

CMBT has a Return On Assets of 4.58%. This is in the better half of the industry: CMBT outperforms 61.14% of its industry peers.
CMBT has a Return On Equity of 29.01%. This is amongst the best in the industry. CMBT outperforms 91.94% of its industry peers.
CMBT has a worse Return On Invested Capital (4.07%) than 62.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CMBT is significantly below the industry average of 21.53%.
The last Return On Invested Capital (4.07%) for CMBT is well below the 3 year average (9.43%), which needs to be investigated, but indicates that CMBT had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROIC 4.07%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBT has a Profit Margin of 25.21%. This is amongst the best in the industry. CMBT outperforms 81.52% of its industry peers.
In the last couple of years the Profit Margin of CMBT has grown nicely.
Looking at the Operating Margin, with a value of 25.71%, CMBT is in the better half of the industry, outperforming 63.98% of the companies in the same industry.
In the last couple of years the Operating Margin of CMBT has grown nicely.
CMBT has a Gross Margin of 54.54%. This is in the better half of the industry: CMBT outperforms 62.56% of its industry peers.
CMBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
CMBT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CMBT has been reduced compared to 5 years ago.
Compared to 1 year ago, CMBT has a worse debt to assets ratio.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.72, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
CMBT has a Altman-Z score of 0.72. This is in the lower half of the industry: CMBT underperforms 60.19% of its industry peers.
CMBT has a Debt/Equity ratio of 3.82. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.82, CMBT is not doing good in the industry: 87.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.55
WACC7.34%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.82 indicates that CMBT may have some problems paying its short term obligations.
CMBT's Current ratio of 0.82 is on the low side compared to the rest of the industry. CMBT is outperformed by 65.40% of its industry peers.
A Quick Ratio of 0.75 indicates that CMBT may have some problems paying its short term obligations.
CMBT has a worse Quick ratio (0.75) than 63.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.75
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.67%.
CMBT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.41% yearly.
CMBT shows a decrease in Revenue. In the last year, the revenue decreased by -1.96%.
Measured over the past years, CMBT shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%

3.2 Future

The Earnings Per Share is expected to decrease by -23.15% on average over the next years. This is quite bad
The Revenue is expected to grow by 32.70% on average over the next years. This is a very strong growth
EPS Next Y-88.7%
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%
EPS Next 5YN/A
Revenue Next Year49.05%
Revenue Next 2Y40.36%
Revenue Next 3Y32.7%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 481.50 indicates a quite expensive valuation of CMBT.
Based on the Price/Earnings ratio, CMBT is valued a bit more expensive than 69.67% of the companies in the same industry.
CMBT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.40.
The Price/Forward Earnings ratio is 5.58, which indicates a rather cheap valuation of CMBT.
91.00% of the companies in the same industry are more expensive than CMBT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CMBT to the average of the S&P500 Index (22.94), we can say CMBT is valued rather cheaply.
Industry RankSector Rank
PE 481.5
Fwd PE 5.58
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMBT indicates a slightly more expensive valuation: CMBT is more expensive than 62.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.3
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
CMBT's earnings are expected to decrease with -23.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)11.09
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.54%, CMBT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.15, CMBT is paying slightly less dividend.
With a Dividend Yield of 0.54, CMBT pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

The dividend of CMBT is nicely growing with an annual growth rate of 116.35%!
CMBT has been paying a dividend for over 5 years, so it has already some track record.
CMBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)116.35%
Div Incr Years2
Div Non Decr Years3
CMBT Yearly Dividends per shareCMBT Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

CMBT pays out 59.41% of its income as dividend. This is a bit on the high side, but may be sustainable.
CMBT's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP59.41%
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%
CMBT Yearly Income VS Free CF VS DividendCMBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
CMBT Dividend Payout.CMBT Dividend Payout, showing the Payout Ratio.CMBT Dividend Payout.PayoutRetained Earnings

CMB TECH NV

NYSE:CMBT (10/17/2025, 8:04:00 PM)

After market: 9.5079 -0.12 (-1.27%)

9.63

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners3.04%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.04B
Analysts83.64
Price Target12.1 (25.65%)
Short Float %2.22%
Short Ratio0.99
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP59.41%
Div Incr Years2
Div Non Decr Years3
Ex-Date10-01 2025-10-01 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.53%
Min EPS beat(2)-198.04%
Max EPS beat(2)-149.02%
EPS beat(4)0
Avg EPS beat(4)-100.08%
Min EPS beat(4)-198.04%
Max EPS beat(4)-3.67%
EPS beat(8)4
Avg EPS beat(8)61.43%
EPS beat(12)7
Avg EPS beat(12)47.26%
EPS beat(16)10
Avg EPS beat(16)41.59%
Revenue beat(2)1
Avg Revenue beat(2)18.49%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)46.8%
Revenue beat(4)3
Avg Revenue beat(4)13.62%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)46.8%
Revenue beat(8)6
Avg Revenue beat(8)20.12%
Revenue beat(12)10
Avg Revenue beat(12)34.18%
Revenue beat(16)14
Avg Revenue beat(16)38.38%
PT rev (1m)11.37%
PT rev (3m)-10.48%
EPS NQ rev (1m)166.6%
EPS NQ rev (3m)-92.98%
EPS NY rev (1m)-64.19%
EPS NY rev (3m)-63.46%
Revenue NQ rev (1m)11.54%
Revenue NQ rev (3m)36.12%
Revenue NY rev (1m)2.46%
Revenue NY rev (3m)39.1%
Valuation
Industry RankSector Rank
PE 481.5
Fwd PE 5.58
P/S 1.99
P/FCF N/A
P/OCF 11.28
P/B 2.29
P/tB 2.67
EV/EBITDA 13.3
EPS(TTM)0.02
EY0.21%
EPS(NY)1.73
Fwd EY17.92%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)0.85
OCFY8.86%
SpS4.83
BVpS4.2
TBVpS3.6
PEG (NY)N/A
PEG (5Y)11.09
Profitability
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROCE 5.15%
ROIC 4.07%
ROICexc 4.16%
ROICexgc 4.26%
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
ROICexc(3y)10.41%
ROICexc(5y)N/A
ROICexgc(3y)10.46%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Debt/EBITDA 7.9
Cap/Depr 492%
Cap/Sales 80.04%
Interest Coverage 1.85
Cash Conversion 42.05%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.75
Altman-Z 0.72
F-Score2
WACC7.34%
ROIC/WACC0.55
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
EPS Next Y-88.7%
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%
Revenue Next Year49.05%
Revenue Next 2Y40.36%
Revenue Next 3Y32.7%
Revenue Next 5YN/A
EBIT growth 1Y-41.59%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year116.95%
EBIT Next 3Y52.74%
EBIT Next 5YN/A
FCF growth 1Y-427.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.74%
OCF growth 3YN/A
OCF growth 5Y11.04%